Oncogene - Table of Contents alert Volume 37 Issue 1

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 37, Issue 1 (January 2018) In this issue Review Original Articles Also new AOP   Sign up for e-alerts Recommend to your library Web feed Subscribe Review Role of SMAD proteins in colitis-associated cancer: from known to the unknown P Chandrasinghe, B Cereser, M Moorghen, I Al Bakir, N Tabassum et al. Oncogene 2017 37: 1 - 7; September 04, 2017; 10.1038/onc.2017.300   Abstract | Full Text Original Articles RCC2 is a novel p53 target in suppressing metastasis C Song, L Liang, Y Jin, Y Li, Y Liu et al. Oncogene 2017 37: 8 - 17; September 04, 2017; 10.1038/onc.2017.306   Abstract | Full Text Atf3 deficiency promotes genome instability and spontaneous tumorigenesis in mice Z Wang, Y He, W Deng, L Lang, H Yang et al. Oncogene 2017 37: 18 - 27; September 04, 2017; 10.1038/onc.2017.310   Abstract | Full Text C-reactive protein binds to integrin a2 and Fc? receptor I, leading to breast cell adhesion and breast cancer progression E-S Kim, S Y Kim, M Koh, H-M Lee, K Kim et al. Oncogene 2017 37: 28 - 38; August 28, 2017; 10.1038/onc.2017.298   Abstract | Full Text Nuclear factor E2-related factor-2 has a differential impact on MCT1 and MCT4 lactate carrier expression in colonic epithelial cells: a condition favoring metabolic symbiosis between colorectal cancer and stromal cells K Diehl, L-A Dinges, O Helm, N Ammar, D Plundrich et al. Oncogene 2017 37: 39 - 51; August 28, 2017; 10.1038/onc.2017.299   Abstract | Full Text Taxane-mediated radiosensitization derives from chromosomal missegregation on tripolar mitotic spindles orchestrated by AURKA and TPX2   Oncogene 2017 37: 52 - 62; September 04, 2017; 10.1038/onc.2017.304   Abstract | Full Text Targeting mitochondrial translation by inhibiting DDX3: a novel radiosensitization strategy for cancer treatment M R Heerma van Voss, F Vesuna, G M Bol, J Afzal, S Tantravedi et al. Oncogene 2017 37: 63 - 74; September 04, 2017; 10.1038/onc.2017.308   Abstract | Full Text Myc target gene, long intergenic noncoding RNA, Linc00176 in hepatocellular carcinoma regulates cell cycle and cell survival by titrating tumor suppressor microRNAs D D H Tran, C Kessler, S E Niehus, M Mahnkopf, A Koch et al. Oncogene 2017 37: 75 - 85; September 04, 2017; 10.1038/onc.2017.312   Abstract | Full Text MRPL33 and its splicing regulator hnRNPK are required for mitochondria function and implicated in tumor progression L Liu, C Luo, Y Luo, L Chen, Y Liu et al. Oncogene 2017 37: 86 - 94; September 04, 2017; 10.1038/onc.2017.314   Abstract | Full Text A novel mouse model of rhabdomyosarcoma underscores the dichotomy of MDM2-ALT1 function in vivo D F Comiskey Jr, A G Jacob, B L Sanford, M Montes, A K Goodwin et al. Oncogene 2017 37: 95 - 106; September 11, 2017; 10.1038/onc.2017.282   Abstract | Full Text MN1 overexpression is driven by loss of DNMT3B methylation activity in inv(16) pediatric AML N S D Larmonie, T C J M Arentsen-Peters, A Obulkasim, D Valerio, E Sonneveld et al. Oncogene 2017 37: 107 - 115; September 11, 2017; 10.1038/onc.2017.293   Abstract | Full Text Carcinoembryonic antigen-related cell adhesion molecule 6 (CEACAM6) promotes EGF receptor signaling of oral squamous cell carcinoma metastasis via the complex N-glycosylation W-F Chiang, T-M Cheng, C-C Chang, S-H Pan, C A Changou et al. Oncogene 2017 37: 116 - 127; September 11, 2017; 10.1038/onc.2017.303   Abstract | Full Text CDKN2B deletion is essential for pancreatic cancer development instead of unmeaningful co-deletion due to juxtaposition to CDKN2A Q Tu, J Hao, X Zhou, L Yan, H Dai et al. Oncogene 2017 37: 128 - 138; September 11, 2017; 10.1038/onc.2017.316   Abstract | Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.